| Syndromic Disorders Caused by Disturbed Human Imprinting | Diana CARLI,Evelise RIBERI,Giovanni Battista FERRERO,Alessandro MUSSA | 1–16 |
| Approach to Abnormal Uterine Bleeding in Adolescents | Cenk YAŞA,Funda GÜNGÖR UĞURLUCAN | 1–6 |
| Dysmenorrhea, Endometriosis and Chronic Pelvic Pain in Adolescents | Aalia SACHEDİNA,Nicole TODD | 7–17 |
| Current Diagnosis, Treatment and Clinical Challenges in the Management of Lipodystrophy Syndromes in Children and Young People | Samim ÖZEN,Barış AKINCI,Elif A. ORAL | 17–28 |
| Where Have the Periods Gone? The Evaluation and Management of Functional Hypothalamic Amenorrhea | Marie Eve Sophie GİBSON,Nathalie FLEMİNG,Caroline ZUİJDWİJK,Tania DUMONT | 18–27 |
| Contraception for Adolescents | Nicole TODD,Amanda BLACK | 28–40 |
| Can Nesfatin-1 Predict Hypertension in Obese Children? | Hatice GÜNEŞ,Filiz ALKAN BAYLAN,Hakan GÜNEŞ,Fatih TEMİZ | 29–36 |
| Treatment with Depot Leuprolide Acetate in Girls with Idiopathic Precocious Puberty: What Parameter should be Used in Deciding on the Initial Dose? | Doğuş VURALLI,Ayfer ALLİKAŞİFOĞLU,İrem İYİGÜN,Dicle CANORUÇ,Alev OZON,E. Nazlı GÖNÇ,Nurgün KANDEMİR | 37–44 |
| Management of Menstrual and Gynecologic Concerns in Girls with Special Needs | Özlem DURAL,İnci Sema TAŞ,Süleyman Engin AKHAN | 41–45 |
| The Significance of Thiol/Disulfide Homeostasis and Ischemiamodified Albumin Levels in Assessing Oxidative Stress in Obese Children and Adolescents | Eda MENGEN,Seyit Ahmet UÇAKTÜRK,Pınar KOCAAY,Özlem KAYMAZ,Salim NEŞELİOĞLU,Özcan EREL | 45–54 |
| Hormone Replacement Therapy in a Patient with Hypogonadism and Coexisting Medical Conditions | Özlem DURAL,Şükran POYRAZOĞLU | 46–49 |
| Conservative Management of Vaginal Hypoplasia | Özlem DURAL,Şükran POYRAZOĞLU | 50–52 |
| Prevalence of Obesity and Metabolic Syndrome in Children with Type 1 Diabetes: A Comparative Assessment Based on Criteria Established by the International Diabetes Federation, World Health Organisation and National Cholesterol Education Program |